LOS ANGELES, Jan. 24, 2013 /PRNewswire via COMTEX/ -- Writers' Group Film Corp. (OTCQB: WRIT) announces that yesterday's New York Times Business Day section featured Writers' Group Film Corp. as a company to keep your eye on. Over the last several days, the company has seen a steady rise in its stock price and in the past 30 days the price has risen 67.66%. You can see the Times' snapshot of the company along with a complete list of all of its latest press releases, financial information and peer performance at:
Thursday, January 24, 2013
WRIT Trading Strong
LOS ANGELES, Jan. 24, 2013 /PRNewswire via COMTEX/ -- Writers' Group Film Corp. (OTCQB: WRIT) announces that yesterday's New York Times Business Day section featured Writers' Group Film Corp. as a company to keep your eye on. Over the last several days, the company has seen a steady rise in its stock price and in the past 30 days the price has risen 67.66%. You can see the Times' snapshot of the company along with a complete list of all of its latest press releases, financial information and peer performance at:
Front Row Networks is a live concert production and distribution company which produces live concerts in 3D for initial digital broadcast into movie theaters worldwide. Following their theatrical run, the films are then licensed to US and international broadcasters, pay channels, PPV markets, DVD and Blu-Ray distributors, and sold on the internet as downloads.
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release regarding the company's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. The company wishes to caution readers not to place undue reliance on such forward-looking statements and as such, speak only as of the date made. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including, but not limited to, those discussed in the Company's latest 10-Q filed November 19, 2012.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment